About Indian Pharmacopoeia IP
A pharmacopoeia, pharmacopeia, or pharmacopoea (from the obsolete typography pharmacopœia, meaning “drug-making”), in its modern technical sense, is a book containing directions for the identification of compound medicines and published by the authority of a government or a medical or pharmaceutical society
History of Indian Pharmacopoeia IP
The actual process of publishing the first Pharmacopoeia started in the year 1944 under the chairmanship of Col. R. N. Chopra. The I. P. list was first published in the year 1946 and was put forth for approval. The titles are suffixed with the respective years of publication, e.g. IP 1996.
Edition Year Volumes Addendum/Supplement of Indian Pharmacopoeia
1st Edition 1955 – Supplement 1960
2nd Edition 1966 – Supplement 1975
3rd Edition 1985 Addendum 1989
Addendum 1991
4th Edition 1996 Addendum 2000
Vet Supplement 2000
Addendum 2002
Addendum 2005
5th Edition 2007 Addendum 2008
6th Edition 2010 Addendum 2012
7th Edition 2014 Addendum 2015
Addendum 2016
8th Edition 2018 Addendum 2019
Addendum 2021
Indian Pharmacopoeia (IP) is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Ministry of Health & Family Welfare, Government of India in fulfilment of the requirements of the Drugs and Cosmetics Act, 1940 and Rules 1945 thereunder. IP is recognized as the official book of standards for the drugs being manufactured and/or marketed in India.
IP contains a collection of authoritative procedures of analysis and specifications of drugs for their identity, purity and strength. The standards of the IP are authoritative in nature and are enforced by the regulatory authorities for ensuring the quality of drugs in India. During quality assurance and at the time of dispute in the court of law the IP standards are legally acceptable. The Standards prescribed in the IP are to establish compliance with regulatory requirements on an article.
The criteria to adhere are: The interpretation of a monograph must be in accordance with all the general requirements, testing methods, texts and notices pertaining to it, in the IP. A product is not of standard quality unless it complies with all the requirements of the monograph.
Indian Pharmacopoeia Commission (IPC)
Indian Pharmacopoeia Commission (IPC) is an autonomous institution of the Ministry of Health and Family Welfare that sets standards for all drugs that are manufactured, sold and consumed in India. The set of standards is published under the title Indian Pharmacopoeia (IP) which has been modelled on and historically follows from the British Pharmacopoeia.
The standards that are in effect since 1 December 2010, are the Indian Pharmacopoeia 2010 (IP 2010). The Pharmacopoeia 2014 was released by Health Minister Ghulam Nabi Azad on 4 November 2013. The Pharmacopoeia 2018 was released by the Secretary, Ministry of Health & Family Welfare, Government of India.
I.P., the abbreviation of ‘Indian Pharmacopoeia’ is familiar to the consumers in the Indian sub-continent as a mandatory drug name suffix. Drugs manufactured in India have to be labelled with the mandatory non-proprietary drug name with the suffix I.P. This is similar to the B.P. suffix for British Pharmacopoeia and the U.S.P. suffix for the United States Pharmacopeia.
The IPC was formed according to the Indian Drugs and Cosmetics Act of 1940 and established by executive orders of the Government of India in 1956
Source:
Indian Pharmacopoeia Commission
First Year B Pharm Notes, Syllabus, Books, PDF Subjectwise/Topicwise
Suggested readings
Recommended readings: